Prevalence and Determinants of Gastroparesis Symptoms among T2DM Patients in Tabuk City
Bashayer Dhaifallah Alanazi, Manea Alhablani, Almaha Alanazi, Maram Mohsen Al Balawi, Amani Salem Alamrani, Nujud Abdulqader Albalawi, Shahad Ali Rfadh, Asmaa Musallam Alfuhaymani, Faris Abdullah Al Hashem
Journal of Pharmaceutical Research International · pp. 47–56 · Published 16 Jun 2022
10.9734/jpri/2022/v34i42A36293Abstract
Background: Development and progression of gastrointestinal complications in T2DM patients are one of the main contributors in the clinical course of the disease. Therefore, early recognition of gastroparesis is an important issue, despite this is not an easy task. Objectives: To estimate the prevalence and identify determinants of gastroparesis symptoms among T2DM patients. Patients and Methods: A cross-sectional study was conducted in Tabuk city, Saudi Arabia among all patients diagnosed with T2DM patients and attended the chronic illness clinics of King Khalid Armed Forces hospital throughout the period April-May, 2022. An interview questionnaire was utilized including 5 main parts: Demographic data of patients, medical history, weight and height measurements, the most recent hemoglobin A1c, and the Gastroparesis Cardinal Symptoms Index (GCSI) to estimate the prevalence of gastroparesis. Results: The study included 348 T2DM patients. More than half of them (57.8%) were females. Their age ranged between 23 and 75 years with an arithmetic mean±standard deviation of 54±11.3 years. The commonest reported gastroparesis symptoms were stomach fullness (45.1%), nausea (42%), loss of appetite (42%)and feeling excessively full after meals (41.1%). Overall, the prevalence of gastroparesis symptoms among T2DM patients was 11.8%. Multivariate logistic regression analysis revealed that females were at high significant risk for developing gastroparesis symptoms compared to males (Adjusted odds ratio “AOR”==2.49, 95% confidence interval “CI”: 1.18-5.27), p=0.016. Participants` glycated hemoglobin level was not significantly associated with gastroparesis symptoms after controlling for confounder effect. Conclusion: The prevalence of gastroparesis symptoms among T2DM patients was not high. Symptoms were more likely to affect female than male patients. However, they were not independently associated with glycemic control or treatment with metformin.
Cited by 0
No indexed citations yet.
Related research
- Assessment of Exclusive Breastfeeding Practice among Palestinian Mothers in the Gaza Strip: A Mixed Methods Design — shares topic coverage
- Impact of the Diet Profile and Alcohol Consumption on Cardiometabolic Risks in Dschang Health District-Cameroon — shares topic coverage
- The Prevalence, Risk Factors and Awareness of Hypertension in an Urban Population of Dehradun, Uttarakhand, India — shares topic coverage
- ABO Blood Groups and Malaria Prevalence in a Referral Hospital in Nigeria — shares topic coverage
- Prevalence of Malaria among Pregnant Women and Children Under Five Years in Abi Local Government Area, Cross River State, Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
23
Page views
0
PDF downloads
3
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.